| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |